Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMYOTROPHIC LATERAL SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01639391
What this trial is testing

Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Institut Pasteur 19
Not applicableWithdrawnNCT03892382
What this trial is testing

Repetitive Transcranial Magnetic Stimulation as Therapy for Apathy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Jagiellonian University
Not applicableLooking for participantsNCT06396260
What this trial is testing

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect

Who this might be right for
Amyotrophic Lateral SclerosisPseudobulbar Affect
Aalborg University Hospital 50
Not applicableLooking for participantsNCT03865420
What this trial is testing

Amyotrophic Lateral Sclerosis (ALS) Families Project

Who this might be right for
ALS
Columbia University 300
Not applicableNot Yet RecruitingNCT05470478
What this trial is testing

IBCI Optimization for Veterans With Paralysis

Who this might be right for
Spinal Cord InjuryAmyotrophic Lateral SclerosisBrain Stem Infarctions+2 more
VA Office of Research and Development 2
Large-scale testing (Phase 3)Not Yet RecruitingNCT07325591
What this trial is testing

Efficacy and Safety of Tazbentetol in ALS Participants

Who this might be right for
Amyotrophic Lateral Sclerosis
Spinogenix 430
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07833618
What this trial is testing

A Phase II Study of ALT001 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. 150
Not applicableStudy completedNCT00718497
What this trial is testing

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 25
Not applicableUnknownNCT05340660
What this trial is testing

MGluR5 Imaging in ALS Using PET

Who this might be right for
Amyotrophic Lateral Sclerosis
Nathalie Braun 30
Testing effectiveness (Phase 2)Study completedNCT03488524
What this trial is testing

Open Label Extension Study of AMX0035 in Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
Amylyx Pharmaceuticals Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00214110
What this trial is testing

Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
University of Wisconsin, Madison 100
Large-scale testing (Phase 3)Study completedNCT00965497
What this trial is testing

Escitalopram (Lexapro) for Depression MS or ALS

Who this might be right for
Major DepressionMultiple SclerosisAmyotrophic Lateral Sclerosis
University of South Carolina 13
Not applicableStudy completedNCT04948346
What this trial is testing

Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03268603
What this trial is testing

Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALSAmyotrophic Lateral Sclerosis
Mayo Clinic 75
Not applicableActive Not RecruitingNCT04858555
What this trial is testing

Staging System in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Limoges 50
Testing effectiveness (Phase 2)Ended earlyNCT05683860
What this trial is testing

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal Dementia
Wave Life Sciences USA, Inc. 8
Not applicableTemporarily Not AvailableNCT06408727
What this trial is testing

Intermediate Expanded Access Protocol CNMAu8.EAP04

Who this might be right for
ALSAmyotrophic Lateral SclerosisPALS
Clene Nanomedicine
Testing effectiveness (Phase 2)Looking for participantsNCT05395624
What this trial is testing

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Parkinson Disease (PD)Alzheimer Disease (AD)+1 more
Ashvattha Therapeutics, Inc. 65
Not applicableStudy completedNCT02572479
What this trial is testing

Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)

Who this might be right for
Amyotrophic Lateral SclerosisDietary HabitsDisorder of Fatty Acid Metabolism
University of Jena 50
Not applicableStudy completedNCT06206629
What this trial is testing

Contralateral R1 in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Hospices Civils de Lyon 120
Next Page